Short Description
High-sensitivity ELISA kit for precise quantification of ALT1 (GPT) protein levels in human biological samples.
ADME Research Domain
Metabolism
Description
CytoFinal™ High-Sensitivity Human Alanine Aminotransferase 1 / ALT (GPT) ELISA Kit provides a robust, in vitro solution for measuring ALT1 protein in human serum, plasma, tissues, and cell lysates. Leveraging a sandwich ELISA format with highly specific antibodies, this kit enables accurate monitoring of liver function, hepatocellular stress, and metabolic enzyme dynamics in clinical and translational research.
Features
Human-specific ALT1 antibodies ensure high selectivity, minimizing cross-reactivity with related aminotransferase isoforms.
Enhanced sensitivity detects low-abundance ALT1 in complex human biological matrices.
96-well microplate format supports high-throughput analysis compatible with standard laboratory ELISA readers.
Complete reagents and calibrated standards enable reproducible results with minimal experimental variation.
Process Relevance
Quantifies ALT1 levels in human samples to assess liver health, hepatocellular injury, and metabolic function.
Application Stage
Clinical research, translational studies, biomarker discovery, and preclinical liver function evaluation.
Applications
Measures ALT1 in human serum, plasma, tissues, and cultured cells for liver function studies, hepatotoxicity assessment, ADME profiling studies, and metabolic pathway analysis.
Target
Human alanine aminotransferase 1 (ALT1/GPT)
Detection Method
Colorimetric
Sample Type
Serum, plasma, cell culture supernatants, tissue homogenates, cell lysates and other biological fluids.
Assay Measures
Quantitative
Research Areas
Clinical hepatology, translational liver research, metabolic disease studies, pharmacology, pharmacokinetics (ADME), preclinical biomarker evaluation, drug-induced liver injury monitoring, etc.